These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36448977)

  • 1. Meta-analysis of peripheral insulin-like growth factor 1 levels in schizophrenia.
    Pejcic AV; Jankovic SM; Janjic V; Djordjic M; Milosavljevic JZ; Milosavljevic MN
    Brain Behav; 2023 Jan; 13(1):e2819. PubMed ID: 36448977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between serum insulin-like growth factor 1 levels and the improvements of cognitive impairments in a subgroup of schizophrenia: Preliminary findings.
    Xiong J; Ding Y; Wu X; Zhan J; Wan Q; Wan H; Wei B; Chen H; Yang Y
    Schizophr Res; 2024 Feb; 264():282-289. PubMed ID: 38198881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired Glucose Homeostasis in First-Episode Schizophrenia: A Systematic Review and Meta-analysis.
    Pillinger T; Beck K; Gobjila C; Donocik JG; Jauhar S; Howes OD
    JAMA Psychiatry; 2017 Mar; 74(3):261-269. PubMed ID: 28097367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antipsychotic treatment on Insulin-like Growth Factor-1 and cortisol in schizophrenia: a longitudinal study.
    Venkatasubramanian G; Chittiprol S; Neelakantachar N; Shetty T; Gangadhar BN
    Schizophr Res; 2010 Jun; 119(1-3):131-7. PubMed ID: 20226630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like Growth Factor 2 (IGF-2) and Insulin-like Growth Factor Binding Protein 7 (IGFBP-7) Are Upregulated after Atypical Antipsychotics in Spanish Schizophrenia Patients.
    Fernández-Pereira C; Penedo MA; Rivera-Baltanas T; Fernández-Martínez R; Ortolano S; Olivares JM; Agís-Balboa RC
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different influences of classical antipsychotics and clozapine on glucose-insulin homeostasis in patients with schizophrenia or related psychoses.
    Melkersson KI; Hulting AL; Brismar KE
    J Clin Psychiatry; 1999 Nov; 60(11):783-91. PubMed ID: 10584769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders.
    Dold M; Samara MT; Li C; Tardy M; Leucht S
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD009831. PubMed ID: 25592299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significantly Higher Peripheral Insulin-Like Growth Factor-1 Levels in Patients With Major Depressive Disorder or Bipolar Disorder Than in Healthy Controls: A Meta-Analysis and Review Under Guideline of PRISMA.
    Tu KY; Wu MK; Chen YW; Lin PY; Wang HY; Wu CK; Tseng PT
    Medicine (Baltimore); 2016 Jan; 95(4):e2411. PubMed ID: 26825882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic combinations for schizophrenia.
    Ortiz-Orendain J; Castiello-de Obeso S; Colunga-Lozano LE; Hu Y; Maayan N; Adams CE
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD009005. PubMed ID: 28658515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin and insulin-like growth factor-1 abnormalities in antipsychotic-naive schizophrenia.
    Venkatasubramanian G; Chittiprol S; Neelakantachar N; Naveen MN; Thirthall J; Gangadhar BN; Shetty KT
    Am J Psychiatry; 2007 Oct; 164(10):1557-60. PubMed ID: 17898347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural brain changes associated with antipsychotic treatment in schizophrenia as revealed by voxel-based morphometric MRI: an activation likelihood estimation meta-analysis.
    Torres US; Portela-Oliveira E; Borgwardt S; Busatto GF
    BMC Psychiatry; 2013 Dec; 13():342. PubMed ID: 24359128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of 42 Pharmacologic Cotreatment Strategies Added to Antipsychotic Monotherapy in Schizophrenia: Systematic Overview and Quality Appraisal of the Meta-analytic Evidence.
    Correll CU; Rubio JM; Inczedy-Farkas G; Birnbaum ML; Kane JM; Leucht S
    JAMA Psychiatry; 2017 Jul; 74(7):675-684. PubMed ID: 28514486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive Function and Variability in Antipsychotic Drug-Naive Patients With First-Episode Psychosis: A Systematic Review and Meta-Analysis.
    Lee M; Cernvall M; Borg J; Plavén-Sigray P; Larsson C; Erhardt S; Sellgren CM; Fatouros-Bergman H; Cervenka S
    JAMA Psychiatry; 2024 May; 81(5):468-476. PubMed ID: 38416480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catechol-O-Methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis.
    Huang E; Zai CC; Lisoway A; Maciukiewicz M; Felsky D; Tiwari AK; Bishop JR; Ikeda M; Molero P; Ortuno F; Porcelli S; Samochowiec J; Mierzejewski P; Gao S; Crespo-Facorro B; Pelayo-Terán JM; Kaur H; Kukreti R; Meltzer HY; Lieberman JA; Potkin SG; Müller DJ; Kennedy JL
    Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26745992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium for schizophrenia.
    Leucht S; Helfer B; Dold M; Kissling W; McGrath JJ
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD003834. PubMed ID: 26509923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies.
    Kishimoto T; Hagi K; Kurokawa S; Kane JM; Correll CU
    Lancet Psychiatry; 2021 May; 8(5):387-404. PubMed ID: 33862018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of Serum Insulin-like Growth Factor-2 Response to Negative Symptom Improvements in Schizophrenia Patients Treated with Atypical Antipsychotics.
    Chao XL; Jiang SZ; Xiong JW; Zhan JQ; Wei B; Chen CN; Yang YJ
    Curr Med Sci; 2020 Jun; 40(3):563-569. PubMed ID: 32681260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-1 (IGF-1) levels in multiple sclerosis patients: A systematic review and meta-analysis.
    Yaghoobpoor S; Fathi M; Vakili K; Sayehmiri F; Alipour M; Miriran ZS; Ghayyem H; Tutunchian Z; Hajibeygi R; Batool Z; Mirzadeh M; Aghazadeh MH; Hajiesmaeili M
    PLoS One; 2024; 19(4):e0297091. PubMed ID: 38630771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzodiazepines for schizophrenia.
    Dold M; Li C; Tardy M; Khorsand V; Gillies D; Leucht S
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD006391. PubMed ID: 23152236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.